Spectrofluorometric determination of labetolol in pharmaceutical preparations and spiked human urine through the formation of coumarin derivative

Journal of Pharmaceutical and Biomedical Analysis

Volumn 30, Issue 4, 2002, Pages 1191-1196

  Belal, F ^a   Al Shaboury, S ^b   Al Tamrah, A S ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Ethyl acetoacetate; Fluorimetry; Labetalol; Tablets; Urine

Indexed keywords

ACETIC ACID DERIVATIVE; COUMARIN DERIVATIVE; ETHYLACETOACETATE; LABETALOL; SULFURIC ACID; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CHEMICAL REACTION; COLOR; COMMERCIAL PHENOMENA; CONCENTRATION (PARAMETERS); DRUG DETERMINATION; DRUG FORMULATION; DRUG URINE LEVEL; FLUORESCENCE; IN VITRO STUDY; PRIORITY JOURNAL; SPECTROFLUOROMETRY; TABLET; URINALYSIS;

ADULT; COUMARINS; HUMANS; LABETALOL; MALE; PHARMACEUTICAL PREPARATIONS; SPECTROMETRY, FLUORESCENCE;

EID: 0037038339     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00471-5     Document Type: Article

References (31)

1. Martindale, In: K. Parfitt (Ed.), The Complete Drug Reference, 32nd edition. Massachusetts, 1999, p. 896.
2. The British Pharmacopoeia, HMSO, London, 2000, Vol. I, p. 780 and Vol. II, p. 573, 574.
3. The United States Pharmacopoea XXIII. The USP Convention, Rockville, 1995, p. 866.
4. The European Pharmacopoeia, Council of Europe, Strasburg, (2001), pp. 1039-1040.
5. Mohamed M.E. Pharmazie. 38:1993;874.
6. Sane R.T., Chandrashekar T.G., Nayak V.G. Indian Drugs. 23:1986;565.
7. Rao G.R., Raghuveer S. Indian Drugs. 23:1986;626.
8. Sastry C.S.P., Krishna D.M. Mikrochim. Acta. 122:1996;87.
9. Sastry C.S.P., Rao S.G., Rama-Srinivas K. Indian Drugs. 35:1998;594.
10. Iorio M.A., Mazzeo-Farina A., Doldo A. J. Pharm. Biomed. Anal. 5:1987;1.
11. Jack D.R., Dean S., Kandall M.J., Laugher S. J. Chromatogr. 196:1980;189.
12. Witek A., Hopkala H., Prazyborowski L. Chem. Anal. 43:1998;817.
13. Witek A., Hopkala H., Matysik G. Chromatographia. 50:1999;41.
14. Zhao H., Li H.Z., Qiu Z.Y. Sepu. 17:1999;369.
15. Bazylak G., Aboul-Enein H.Y. J. Liq. Chromatogr. Relat. Technol. 22:1999;1171.
16. Ceniceros C., Maguregui M.I., Jimenez R.M., Alonso R.M. J. Chromatogr. B. 705:1998;97.
17. Dakers J.M., Boulton D.W., Fawcett J.P. J. Chromatogr. B. 704:1997;215.
18. Wq J.C., Lord H.L., Pawliszyn J., Kataoka H. Microcolumn Sep. 12:2000;255.
19. Gergov M., Robson J.N., Duchoslav E., Ojanpera I. J. Mass Spectrom. 35:2000;912.
20. You C.H., Fang H.J. Yaowu Fenxi Zazhi. 12:1992;195.
21. Changchit A., Gal J., Zirrolli J.A. Biol. Mass Spectrom. 20:1991;751.
22. Carda-Broch S., Rapado-Martinez R., Esteve-Romero I., Garcia-Alvarez-Coque M.C. J. Chromatogr. Sci. 37:1999;93.
23. Tamisier-Karolak S.L., Stenger M.A., Bommart A. Electrophoresis. 20:1999;2656.
24. Wang F., Khaledi M.G. Electrophoresis. 19:1998;2095.
25. Karlsson C., Wikstrom H., Armstrong D.W., Owens P.K. J. Chromatogr. A. 897:2000;349.
26. Beses M., Bartos J. Talanta. 14:1967;1097.
27. Elderfield R.C. Heterocyclic Compounds Series. 2:1951;181 Wiley, New York.
28. El Walily A.F.M., Gazy A.A.K., Belal S.F., Khamis E.F. J. Pharm. Biomed. Anal. 20:1999;643.
29. Moffat A.C. Clarke's Isolation and Identification of Drugs. 2nd Edition: 1986; The Pharmaceutical Press, London.
30. Miller J.C., Miller J.N. Statistics for Analytical Chemistry. 1983;Wiley, New York.
31. Furniss B.S., Hounaford A.J., Smith P.W.G., Tachell A.R. Vogel's Textbook of Organic Chemistry. 5th edition: 1989; 1190 Longman, New York.